ScreenerHero

MEDIC Medicon Hellas S.A.

ATH · GR · Healthcare · Drug Manufacturers - Specialty & Generic · mediconsa.com
2.910EUR-1.36%Mkt Cap: 13.98M $P/E: 17.02

Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and p…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap13.98M USD
Enterprise Value17.41M USD
Revenue (TTM)20.25M USD
Gross Profit14.83M USD
Net Income (TTM)2.68M USD
Revenue/Share4.21 EUR
Last Price2.910 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees148
CountryGR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)17.02
P/E (Forward)—
PEG—
EV/EBITDA3.84
EV/Revenue0.86
P/S0.70
P/B0.62
EPS (TTM)0.17
EPS (Forward)—
52W Range
2.32075% of range3.110
52W High3.110 EUR
52W Low2.320 EUR
Profitability
Gross Margin73.24%
Oper. Margin17.85%
EBITDA Margin22.39%
Profit Margin13.23%
ROE12.43%
ROA5.71%
Growth
Revenue Growth7.60%
Earnings Growth92.10%
Cash Flow & Leverage
Operating CF6.23M USD
CapEx (TTM)—
FCF Margin-12.14%
FCF Yield-17.58%
Net Debt2.88M USD
Net Debt/EBITDA0.64
Balance Sheet
Debt/Equity41.31
Current Ratio5.76
Quick Ratio3.52
Book Value/Sh4.75 EUR
Cash/Share1.39 EUR
Dividends
Fwd Div Rate0.15 EUR
Trail. Div Rate0.00 EUR
Div. Yield5.00%
5Y Avg Yield10.83%
Payout Ratio—
Ex-Div DateJul 13, 2026
Pay DateJul 11, 2001
Splits
Last Split22.03045:21.03045
Split DateMar 4, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.42M
Float—
Insiders44.74%
Institutions0.00%
Technical
SMA 502.765 (+5.3%)
SMA 2002.662 (+9.3%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)5.09K
Avg Vol (10d)11.14K
Technical Indicators
RSI (14)57.2
MACD0.0506
MACD Signal0.0267
MACD Hist.+0.0239
BB Upper3.025 EUR
BB Middle2.795 EUR
BB Lower2.564 EUR
BB Width16.52%
ATR (14)0.0965 EUR
Vol Ratio (20d)0.47x